1st Translational Research Conference Chronic Lymphocytic Leukaemia: Postponed until November 17-19, 2020

1st Translational Research Conference 
Chronic Lymphocytic Leukaemia

Postponed : until November 17-19, 2020

Chairpersons: Jennifer Brown, Paolo Ghia, Michael Hallek
(March 20-22, 2020 - Paris, France)

CONFERENCE UPDATE:
novel coronavirus (COVID-19)

---

 
Since the last update published on the ESH website, concern related to the rapid spread of the COVID-19 virus has continued to grow at the global level.  

In view of the increasing number of infected patients in countries worldwide, many medical organizations and health authorities have decided to implement travel restrictions in order to limit exposure to the virus and ensure that patients at home continue to benefit from the presence of their medical specialists.  These measures concern many speakers and registered participants of the ESH conference cited in reference.

Our first priority is your safety and that of your patients. We also want to make sure that participants who come to ESH benefit from the presence of a complete faculty of global experts in their field. For these reasons, we have decided to postpone the meeting and to re-schedule it later this year, November 17-19, 2020, at the same venue.   

If you are a confirmed registrant in this ESH conference, please be assured that your registration in the meeting remains valid for the new dates, later this year. We will continue to update the information on the ESH website and also to keep you updated directly but please do not hesitate to contact us if you have questions.  

Please also be informed that Air France and other airline companies have announced the possibility to rebook flights at no extra cost. We invite you to make contact with your travel agency in this regard.  

We apologize for the inconvenience and we thank you for your understanding.  

We look forward to welcoming you the 1st Translational Research Conference on Chronic Lymphocytic Leukaemia and we will be in touch with you with further information very shortly.  

The ESH Team